ArticleCancers2021

Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures.

Annabel Meireson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.